MarketCap
Facebook
X
TelegramAnnual report 2024
added 12-27-2025
Check-Cap Ltd. ROE Ratio 2011-2025 | CHEK
Annual ROE Ratio Check-Cap Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1734.41 | -74.17 | -46.25 | -33.94 | -84.54 | -221.94 | -81.27 | -165.47 | -84.81 | -97.17 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1734.41 | -221.94 | 84.49 |
Quarterly ROE Ratio Check-Cap Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -13.87 | -27.74 | -38.84 | -24.98 | -44.23 | -49.61 | -83.31 | -64.06 | -89.25 | -95.19 | -69.48 | -44.29 | -58.63 | -47.77 | -92.31 | -77.98 | -115.06 | -137.81 | -74.16 | -37.08 | -59.91 | -45.67 | -45.67 | -22.83 | -36.6 | -27.54 | -27.54 | -13.77 | -13.77 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -13.77 | -137.81 | -54.45 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M |  USA |
 |
Brainsway Ltd.
BWAY
|
-27.43 | $ 19.02 | 0.21 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 20.99 | 1.77 % | $ 226 M |  China |
 |
Co-Diagnostics
CODX
|
-41.08 | $ 0.17 | -3.71 % | $ 4.99 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 39.06 | -0.64 % | $ 1.08 B | USA |
 |
Danaher Corporation
DHR
|
7.87 | $ 230.1 | -0.25 % | $ 168 B | USA |
 |
DarioHealth Corp.
DRIO
|
-102.21 | $ 10.95 | 2.34 % | $ 311 M | Israel |
 |
BioNano Genomics
BNGO
|
-316.66 | $ 1.52 | 1.23 % | $ 1.93 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-35.99 | $ 101.89 | -0.01 % | $ 18.9 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
DexCom
DXCM
|
26.18 | $ 66.73 | -0.5 % | $ 25.8 B | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 26.31 | -0.7 % | $ 795 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
-72.81 | $ 18.96 | -0.6 % | $ 1.02 B | USA |
 |
Celcuity
CELC
|
-96.68 | $ 99.66 | -0.26 % | $ 3.93 B | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
Anixa Biosciences
ANIX
|
-62.78 | $ 3.14 | 0.64 % | $ 100 K | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
22.63 | $ 226.62 | -0.47 % | $ 41.1 B | USA |
 |
Guardant Health
GH
|
312.48 | $ 102.42 | 1.81 % | $ 12.6 B | USA |
 |
NeoGenomics
NEO
|
-8.72 | $ 11.95 | -2.29 % | $ 1.51 B | USA |
 |
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | USA |
 |
Myriad Genetics
MYGN
|
-18.16 | $ 6.14 | -0.57 % | $ 556 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-449.46 | $ 4.5 | -5.46 % | $ 2.42 M | USA |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 7.07 | 0.21 % | $ 1.53 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
9.97 | $ 27.22 | -0.62 % | $ 20 B |  Niderland |
 |
Personalis
PSNL
|
-40.05 | $ 8.02 | 0.63 % | $ 475 M | USA |
 |
Quidel Corporation
QDEL
|
60.8 | $ 28.81 | -1.67 % | $ 1.21 B | USA |
 |
National Research Corporation
NRC
|
63.26 | $ 18.73 | 0.43 % | $ 460 M | USA |
 |
RadNet
RDNT
|
0.31 | $ 71.37 | -0.17 % | $ 5.21 B | USA |
 |
Illumina
ILMN
|
-51.54 | $ 131.22 | -1.15 % | $ 20.9 B | USA |
 |
Charles River Laboratories International
CRL
|
0.64 | $ 200.86 | -0.55 % | $ 10.3 B | USA |
 |
Soleno Therapeutics
SLNO
|
-71.74 | $ 45.87 | -0.91 % | $ 1.84 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
12.85 | $ 174.42 | -0.61 % | $ 19.4 B | USA |
|
Biodesix
BDSX
|
-205.65 | $ 6.78 | 0.86 % | $ 879 M | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
9.26 | $ 251.89 | -0.47 % | $ 21.1 B | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 182.34 | -0.36 % | $ 15 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
55.65 | $ 679.3 | -0.44 % | $ 56 B | USA |
 |
Lantheus Holdings
LNTH
|
28.72 | $ 67.01 | -0.22 % | $ 4.64 B | USA |